Physician profile
Navin Reddy
NPI 1487818670
$2,402.98
in general payments reported to CMS, 2019-2025
18 companies · $376 in 2025
The $376 reported for 2025 was more than what a typical Psychiatry provider received nationally (typical 2025 total: $176).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,477 · 2020: $325 · 2021: $95.45 · 2022: $22.42 · 2023: $83.85 · 2024: $23.03 · 2025: $376.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $483.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $483.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $442.20 | 2019-2020 | |
| Lundbeck LLC | $326.79 | 2019-2020 | |
| Indivior INC. | $298.72 | 2019-2025 | Sublocade |
| Shire North American Group INC | $211.50 | 2019 | |
| Otsuka America Pharmaceutical, INC. | $174.28 | 2019-2020 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $159.36 | 2021-2025 | Caplyta |
| Bausch Health US, LLC | $132.96 | 2019-2021 | |
| Avanir Pharmaceuticals, INC. | $104.83 | 2019 | |
| Sunovion Pharmaceuticals INC. | $91.24 | 2019-2020 | |
| Alkermes, INC. | $88.50 | 2019-2020 | |
| Abbvie INC. | $81.55 | 2021-2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $75.74 | 2019-2020 | |
| Teva Pharmaceuticals USA, INC. | $60.60 | 2019-2020 | |
| Csl Behring | $40.14 | 2023 | Kcentra |
| Neos Therapeutics, LP | $33.75 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Adlon Therapeutics L.P. | $33.57 | 2019-2020 | |
| Titan Pharmaceuticals, INC. | $25.69 | 2020 | |
| Janssen Pharmaceuticals, INC | $21.56 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Navin Reddy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.